Search Results - Wu YL

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    The Predictive Value of Heparin-Binding Protein and D-Dimer in Patients with Sepsis by Tang J, Yuan H, Wu YL, Fu S, Pan XY

    Published in International Journal of General Medicine (2023-06-01)
    Get full text
    Article


  2. 2

    Development and Validity and Reliability of an Instrument to Assess Patient’s Spiritual Well-Being by Fang CK, Cheng SY, Pi SH, Wu YL, Lin KC, Pan RY

    Published in Journal of Multidisciplinary Healthcare (2024-07-01)
    Get full text
    Article


  3. 3

    Clinical Features and Prognosis of Patients with COVID-19 and B-Cell Non-Hodgkin Lymphoma by Lin YQ, Li N, Wu YL, Ma JB, Gao HN, Zhang X

    Published in Infection and Drug Resistance (2024-10-01)
    Get full text
    Article


  4. 4

    Ultrasound-Indicated Cervical Cerclage Efficacy Between 16 and 28 Weeks of Gestation in Twin Pregnancy: Retrospective Cohort Study by Yao LP, Yang Q, Pei JD, Wu YL, Wan S, Chen ZQ, Hua XL

    Published in International Journal of General Medicine (2022-03-01)
    Get full text
    Article


  5. 5

    Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer by Liu SYM, Xie Z, Yan L, Jie GL, Deng JY, Zhang Q, Huang Z, Wang J, Zhang Z, Shao Y, Meng H, Zhang Y, Zhang XC, Chen HJ, Zhong WZ, Zhou Q, Wu YL

    Published in Lung Cancer: Targets and Therapy (2026-05-01)
    Get full text
    Article


  6. 6

    Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy by Yu BF, Lu YF, Gao F, Jing P, Han W, Zhang PC, Liu GL, Ru N, Cui GH, Xu XH, Sun CL, Guan CJ, Che YB, Wu YL, Ma ZL, Fu Q, Liu J, Wang HY

    Published in Lung Cancer: Targets and Therapy (2015-01-01)
    Get full text
    Article


  7. 7

    Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy by Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF

    Published in Journal of Hepatocellular Carcinoma (2015-06-01)
    Get full text
    Article


  8. 8

    ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab by Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D'Alessio A

    Published in Journal of Hepatocellular Carcinoma (2025-04-01)
    Get full text
    Article


Search Tools: